Table 4

- Correlation of non-alcoholic fatty liver disease with glomerular filtration rate, chronic kidney disease grade, the incidence of albuminuria, atherogenic index of plasma categories, and the incidence of dyslipidemia.

NAFLDGFRGrade CKDAlbuminuria
Participants (n=735)<60>60P-value*Grade 1Grade 2Grade 3Grade 4Grade 5P-value*A1A2A3P-value*
NAFLD patients at 2018-2019245 (33.3)490 (66.7)0.02417 (56.7)313 (42.6)5 (0.7)0 (0.0)0 (0.0)0.03355 (48.3)375 (51.0)5 (0.7)0.02
NAFLD patients after 4 years follow up390 (53.1)345 (46.9) 225 (30.6)370 (50.3)100 (13.6)35 (4.8)5 (0.7) 300 (40.8)385 (52.4)50 (6.8) 
Participants (n=735)LipidAIP (risk of CVD) 
DyslipidemiaNormalP-value*Low riskIntermediate riskHigh riskP-value*
NAFLD patients at 2018-2019325 (44.2)410 (55.8)0.05410 (55.8)300 (40.8)25 (3.4)0.04
NAFLD patients after 4 years follow up370 (50.3)365 (49.7)305 (41.5)370 (50.3)60 (8.2)

Values are presented as numbers and percentages (%).

Grade CKD groups: p-value for Grade 1 vs other groups. Albuminuria groups: p-value for A1 vs other groups. AIP (risk of CVD) groups: p-value for low-risk vs other groups. NAFLD: nonalcoholic fatty liver disease, GFR: glomerular filtration rate, CKD: chronic kidney disease, CVD: cardiovascular disease, AIP: atherogenic index of plasma

  • * Chi-square test. AIP of <0.11 low risk of CVD, whereas AIP values between 0.11-0.21= intermediate risk, AIP >0.21= high risk of CVD.